 BD Becton, Dickinson and Company NYSE: BDX, a leading global medical technology company, today announced the formation of a strategic, public-private partnership with the Biomedical Advanced Research and Development Authority BARDA, part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness and Response, to develop new manufacturing lines for injection devices that will provide priority access to the U.S. government for hundreds of millions of syringes and needles to support current and future pandemic vaccination efforts. 